tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

KZIA Stock Latest News

Kazia Therapeutics Issues Prefunded Warrant for ADS Purchase
Company AnnouncementsKazia Therapeutics Issues Prefunded Warrant for ADS Purchase
5d ago
6K
KZIA
Kazia Therapeutics to sell 1.33M ADS at $1.50 in registered direct offering
PremiumThe Fly
Kazia Therapeutics to sell 1.33M ADS at $1.50 in registered direct offering
8d ago
KZIA
Kazia Therapeutics Charts Path Forward for Paxalisib After FDA Feedback
PremiumCompany Announcements
Kazia Therapeutics Charts Path Forward for Paxalisib After FDA Feedback
18d ago
6K
KZIA
Kazia announces FDA says OS data supports standard, not accelerated approval
PremiumThe Fly
Kazia announces FDA says OS data supports standard, not accelerated approval
18d ago
KZIA
Kazia Therapeutics Presents Promising Data on Paxalisib for Breast Cancer Treatment
PremiumCompany Announcements
Kazia Therapeutics Presents Promising Data on Paxalisib for Breast Cancer Treatment
1M ago
6K
KZIA
Kazia Therapeutics Secures Nasdaq Compliance
PremiumCompany AnnouncementsKazia Therapeutics Secures Nasdaq Compliance
2M ago
6K
KZIA
Kazia Therapeutics management to meet with Maxim
Premium
The Fly
Kazia Therapeutics management to meet with Maxim
2M ago
KZIA
Kazia Therapeutics Advances Paxalisib with FDA Meeting
Premium
Company Announcements
Kazia Therapeutics Advances Paxalisib with FDA Meeting
2M ago
6K
KZIA
Kazia Therapeutics announces granting of Type C meeting with FDA
PremiumThe Fly
Kazia Therapeutics announces granting of Type C meeting with FDA
3M ago
KZIA
Upcoming Stock Splits This Week (October 28 to November 1) – Stay Invested
PremiumMarket News
Upcoming Stock Splits This Week (October 28 to November 1) – Stay Invested
3M ago
AHT
ALBT
Kazia Therapeutics trading halted, news pending
PremiumThe Fly
Kazia Therapeutics trading halted, news pending
3M ago
KZIA
Kazia Therapeutics Adjusts ADS Ratio to Boost Nasdaq Listing
PremiumCompany Announcements
Kazia Therapeutics Adjusts ADS Ratio to Boost Nasdaq Listing
3M ago
6K
KZIA
Kazia Therapeutics Reveals Promising Brain Cancer Study
PremiumCompany AnnouncementsKazia Therapeutics Reveals Promising Brain Cancer Study
4M ago
6K
KZIA
Kazia Therapeutics announces presentation of Phase 1 data on paxalisib
Premium
The Fly
Kazia Therapeutics announces presentation of Phase 1 data on paxalisib
4M ago
KZIA
Kazia Therapeutics Reveals Hopeful Ovarian Cancer Study
Premium
Company Announcements
Kazia Therapeutics Reveals Hopeful Ovarian Cancer Study
4M ago
6K
KZIA
Kazia Therapeutics announces presentation of EVT801
PremiumThe Fly
Kazia Therapeutics announces presentation of EVT801
4M ago
KZIA
Kazia Therapeutics Advances Cancer Treatment Options
PremiumCompany Announcements
Kazia Therapeutics Advances Cancer Treatment Options
4M ago
6K
KZIA
Kazia Therapeutics executes licensing agreement with QIMR Berghofer Medical
PremiumThe Fly
Kazia Therapeutics executes licensing agreement with QIMR Berghofer Medical
4M ago
KZIA
Kazia Therapeutics files to sell $100M of American Depositary Shares
PremiumThe Fly
Kazia Therapeutics files to sell $100M of American Depositary Shares
5M ago
KZIA
Kazia’s Paxalisib Shows Potential in Glioblastoma Trial
PremiumCompany AnnouncementsKazia’s Paxalisib Shows Potential in Glioblastoma Trial
6M ago
6K
KZIA
Kazia Therapeutics reports results from GBM-AGILE phase II/III study
Premium
The Fly
Kazia Therapeutics reports results from GBM-AGILE phase II/III study
6M ago
KZIA
Kazia Therapeutics files to sell 1.1M ADSs for holders
Premium
The Fly
Kazia Therapeutics files to sell 1.1M ADSs for holders
7M ago
KZIA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >